February 6, 2026

Pharvaris N.V. (PHVS) Stock Analysis: A Promising 85% Potential Upside for Biotech Investors

Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to treating rare diseases, particularly angioedema. With..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a 13.62% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a significant player in the healthcare sector specializing in medical care facilities, is currently trading at $8.74, which reflects a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 19.10% Potential Upside in the Healthcare Sector

Investors looking to explore opportunities within the biotechnology sector may find Fortrea Holdings Inc. (FTRE) intriguing, especially given its potential for a 19.10% upside based on..

Valneva SE (VALN) Stock Analysis: A 36.25% Potential Upside in the Vaccine Market

Investors with an interest in the biotechnology sector might find Valneva SE (NASDAQ: VALN) an intriguing opportunity. This French-based specialty vaccine company, with a market cap..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Biotechnology Gem with 271% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a prominent player in the biotechnology sector, is catching the attention of investors with its remarkable potential for substantial returns. The..

InnovAge Holding Corp. (INNV) Stock Analysis: What a 33% Downside Means for Investors

InnovAge Holding Corp. (NASDAQ: INNV) is at the forefront of providing comprehensive medical and ancillary services tailored for seniors who wish to live independently. Operating through..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Sector with a 6.10% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, continues to capture investor attention..

AbCellera Biologics Inc. (ABCL): Investor Outlook Highlights a 253.72% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering player in the biotechnology sector, has become a focal point for investors looking to capitalize on its significant growth..

uniQure N.V. (QURE) Stock Analysis: A Biotech Gem with a 117% Potential Upside

uniQure N.V. (QURE), a prominent player in the biotechnology sector, stands out as a fascinating investment opportunity with a staggering potential upside of 117.08%. Operating out..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Potential Upside Amid Challenges in the Medical Device Market

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is an intriguing name in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Ponte Vedra,..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 149% Potential Upside in Gene Therapy Innovations

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stands out in the biotechnology sector with its ambitious focus on developing gene therapies for monogenic diseases of the central..

Akso Health Group (AHG) Stock Analysis: Exploring a 415.80% Revenue Growth in the Medical Distribution Sector

Investors looking for promising opportunities in the healthcare sector may find Akso Health Group (AHG) an intriguing candidate. Based in Qingdao, China, this company has carved..

RxSight, Inc. (RXST) Stock Analysis: Navigating Growth Potential Amidst a 32.85% Upside Target

For investors seeking opportunities in the healthcare sector, RxSight, Inc. (NASDAQ: RXST) offers a compelling narrative, especially with a potential upside of 32.85% based on analyst..

Talkspace, Inc. (TALK) Stock Analysis: Unpacking the 31.93% Potential Upside for Investors

Investors seeking exposure in the burgeoning field of virtual healthcare might find Talkspace, Inc. (NASDAQ: TALK) to be a compelling opportunity. With a market capitalization of..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93.96% Potential Upside in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is emerging as a noteworthy player in the biotechnology sector, capturing investor interest with its promising pipeline and substantial potential upside..

Sionna Therapeutics (SION) Stock Analysis: Evaluating a 27% Potential Upside in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION), a notable player in the biotechnology sector, is making waves with its ambitious approach to treating cystic fibrosis (CF). With a..

COMPASS Pathways Plc (CMPS): Analyst Ratings Suggest a 202% Upside in Psychedelic Therapy Stock

Investors looking for groundbreaking opportunities in the healthcare sector might find COMPASS Pathways Plc (NASDAQ: CMPS) intriguing. Known for its pioneering work in psychedelic therapies, particularly..

Definitive Healthcare Corp. (DH) Stock Analysis: Unpacking the 99% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) is positioning itself as an intriguing opportunity for investors willing to navigate the complexities of the health information services sector. With..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking the 120% Upside Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its promising pipeline dedicated to addressing unmet medical needs...

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Biotech Innovator with a 47.66% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising developments in precision medicine. Specializing in fibroblast..

Search

Funds

February 6, 2026

Search

Funds

February 6, 2026

FTSE 100

Funds